Rivastigmine Patch in Chinese Patients with Probable Alzheimer's disease: A 24-week, Randomized, Double-Blind Parallel-Group Study Comparing Rivastigmine Patch (9.5 mg/24 h) with Capsule (6 mg Twice Daily)

Author:

Zhang Zhen-Xin1,Hong Zhen2,Wang Yan-Ping3,He Li4,Wang Ning5,Zhao Zhong-Xin6,Zhao Gang7,Shang Lan8,Weisskopf Marianne9,Callegari Francesca9,Strohmaier Christine9

Affiliation:

1. Peking Union Medical College Hospital; Beijing China

2. Huashan Hospital Affiliated to Fudan University; Shanghai China

3. No 2 Hospital affiliated to Guangzhou Medical University; Guangzhou City China

4. Department of Neurology; West China Hospital of Sichuan University; Chengdu China

5. Department of Neurology; First Affiliated Hospital; Fujian Medical University; Fuzhou China

6. Shanghai Changzhen Hospital; Shanghai China

7. Xijing Hospital; Shaanxi China

8. Huilongguan Hospital; Beijing China

9. Novartis Pharma AG; Basel Switzerland

Publisher

Wiley

Subject

Pharmacology (medical),Physiology (medical),Psychiatry and Mental health,Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3